Home/Filings/4/0001144204-16-076465
4//SEC Filing

ATOSSA GENETICS INC 4

Accession 0001144204-16-076465

$ATOSCIK 0001488039operating

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 1:55 PM ET

Size

5.3 KB

Accession

0001144204-16-076465

Insider Transaction Report

Form 4
Period: 2016-01-19
Chen Shu-Chih
DirectorChief Scientific Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2016-01-19$0.20/sh+50,000$10,0004,318,315 total(indirect: See Footnote)
Footnotes (2)
  • [F1]Represents 50,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
  • [F2]Consists of 4,318,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity.

Issuer

ATOSSA GENETICS INC

CIK 0001488039

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001488039

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 1:55 PM ET
Size
5.3 KB